The Journal of Clinical and Experimental Pathology (ISSN: 2161-0681) deals with research on infectious disorders associated with immune system and immunological disorders, infectious diseases, treatment of infectious diseases, infectious medicine, epidemiology, diagnostic tests of infectious diseases, infection control, pathophysiology, clinical pathology , preventive medicine. Clinical Pathology deals with patient care, diagnostic services, novel treatments and research on immune infections.

The pathology report describes the pathologist’s diagnosis based on his or her examination of a tissue sample taken from your tumor, or in the case of blood cancers, a sample taken from one of your lymph nodes or bone marrow. If cancer is diagnosed, the report will provide specific information about the characteristics of the cancer cells, which helps your doctor recommend the best treatment options for you.

The report details the type of cancer involved, whether it’s invasive and able to spread to other parts of the body, and how far the cancer has penetrated into surrounding healthy tissues. It also includes information about:

Histologic grade, which compares the size, shape, and other characteristics to those of your healthy cells. For example, a tumor with cells that look more like healthy cells is called low grade or well differentiated, and is often associated with a better prognosis, or chance of recovery.
Mitotic rate, which details how often the cancer cells are dividing. Tumors with fewer dividing cells typically are low grade and are more likely to correspond to a better prognosis for the patient.
Lymph node status, which documents whether the cancer has spread to nearby lymph nodes — small, bean-shaped glands that help fight infection — or other organs. If the tumor has invaded the blood vessels or lymph vessels that flow into the lymph nodes, there is a greater chance that the cancer has metastasized (spread) to other parts of the body.
Stage, or extent of cancer in the body based on the tumor’s size, location, and spread. The pathologic stage, along with the results of other diagnostic tests, helps guide a person’s treatment options.
Other test results indicating the presence of hormone receptors or other tumor markers.

On the occasion of its 10 years, Successful Journey, Journal of Clinical and Experimental Pathology decided to provide a partial waiver on its article processing charges to promote quality research from across the nations of the globe to encourage the latest research in the field of Infections, Diseases and Medicine. Journal of Clinical and Experimental Pathology also planning to release a special issue on its new approaches.

Regards,

Robert Solomon

Editorial office

Journal of Clinical and Experimental Pathology

E-mail: pathol@eclinicalsci.com

Reach Us: +1-947-333-4405